The purpose of the study is to assess the average of the "State Anxiety" score of the State Trait Inventory Anxiety at the end of the third cycle of chemotherapy compared to the pre-treatment score (inclusion)
Patient with cancer treated with adjuvant chemotherapy with an interval of 14 or 21 days for the first 3 cycles;
Chemotherapy naïve patient;
Patient speaking and understanding French and able to complete the questionnaires;
Patient having been informed and having signed an informed consent form to participate in the study.
Patient who has already benefited from socio-aesthetic care;
Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator